TrialCancer2021

A phase II basket trial of Dual Anti-CTLA-4 and Anti-PD-1 Blockade in Rare Tumors (DART) SWOG S1609: High-grade neuroendocrine neoplasm cohort.

Sandip Pravin Patel et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.